news

Syngene announces second year of STEM scholarship and mentorship program for women in collaboration with RICH

Jun 19, 2024 · Source: cision
  • 30 women from tier 2 and 3 institutions have been selected for the second cohort of the program
  • 21 women successfully completed the 2023 program; 12 landed industry jobs, while 9 extended their internships to pursue master's degrees

HYDERABAD, India, June 19, 2024 -- Syngene International Ltd., a leading integrated research, development and manufacturing services company, announced the second cohort of the Scholarship, Mentoring and Industry Orientation for Women in STEM (science, technology, engineering, and mathematics) in collaboration with the Research and Innovation Circle of Hyderabad (RICH). This program offers scholarships to women studying STEM subjects at tier 2 and 3 institutions across various regions of the country, to enable them to gain industry experience in research institutions and companies and receive mentoring support.

Out of 549 applications, 216 profiles were shortlisted based on academic merit, socio-economic background, and STEM disciplines. One-on-one interviews were conducted with 151 students to assess their achievements and research interests. The top 60 applications were then reviewed by the Selection Committee, comprising experts from both industry and academia. As a result, the second cohort of the program has identified 30 women, with 10 selected from undergraduate programs and 20 from postgraduate programs.

During the launch of this cohort, Dr. Jayesh Ranjan, IAS, Special Chief Secretary to Government, I&C and IT Dept, Govt. of Telangana; Ms. G. Nirupa, Joint Secretary, Telengana Social Welfare Residential Educational Institutional Society (TGSWREIS) and Telengana Tribal Welfare Residential Educational Institutional Society (TGTWREIS), Govt. Of Telengana; Dr. Vishal Choudhary, Scientist F, Office of Principal Scientific Adviser, Govt. of India; Dr. Sridevi Khambhampaty, Vice President, Biopharmaceutical Development, Syngene International; and Dr. Anupama Shetty, Mission Director, Biocon Foundation, were in attendance.

Sridevi Khambhampaty, Vice President – Biopharmaceutical Development from Syngene International Ltd., said, "We are delighted with the outcomes of the first cohort of the program. Encouraging women in STEM subjects is not just about achieving gender parity — it's about unlocking innovation. Diverse perspectives breed creativity, and by fostering an inclusive environment, we empower women to pursue their passion and enrich our collective pool of knowledge. By offering these opportunities, we are investing in the future of science and technology."

Despite increased female enrolment in existing STEM programs, dropout rates and limited career opportunities persist, especially for women from tier 2 and 3 cities. The Syngene/RICH program addresses these issues by offering scholarships and mentorship, enabling students to gain internships and practical experience in top research institutions and industries. Scholarships alleviate the financial burden for students, while mentorship provides career guidance, exposure to emerging STEM fields, and bridges the gap between theory and practice. This support boosts confidence, enhances project quality, facilitates networking, and empowers women to excel.

21 women who successfully completed the first cohort of the program were felicitated during this launch. Ms. Akshita Kulshrestha from the first cohort of the 'Women in STEM' program, said, "The mentorship support from Mr. Narasimha Reddy Dondeti and Mr. Suneelshekhar Yapara from Syngene International has been a cornerstone of my academic and career growth. They offered invaluable guidance and insights that have shaped my journey in significant ways. They have provided real-world context, skill development, networking opportunities, project guidance, career insights, and given me the confidence to pursue my aspirations in scientific research." 

Ms. Rashmi Pimpale, CEO, Research and Innovation Circle of Hyderabad (RICH), said, "I am excited to reflect on the impact we have achieved through the collaboration with Syngene. Beyond financial assistance, our aim was to provide marginalised female students with invaluable hands-on learning opportunities in the top research and development institutions and industries located in Hyderabad. We believe this exposure acts as a bridge between academia and industry, igniting a passion for STEM among young women."

The program was delivered by Research and Innovation Circle of Hyderabad, Biocon Foundation and Syngene Scientific Services Ltd.

About Syngene

Syngene International Ltd. (BSE: 539268) (NSE: SYNGENE) (ISIN: INE 398R01022) is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. Syngene's more than 6000 scientists offer both skills and the capacity to deliver great science, robust data security, and world class manufacturing, at speed, to improve time-to-market and lower the cost of innovation. With a combination of dedicated research facilities for Amgen, Baxter, and Bristol-Myers Squibb as well as 2 Mn sq. ft of specialist discovery, development and manufacturing facilities, Syngene works with biotech companies pursuing leading-edge science, as well as multinationals, including GSK, Zoetis and Merck KGaA. For more details, visit www.syngeneintl.com. For the Company's latest Environmental, Social, and Governance (ESG) report, visit https://esgreport.syngeneintl.com/.

About Research and Innovation Circle of Hyderabad (RICH)

Research and Innovation Circle of Hyderabad (RICH) is the Hyderabad Science & Technology (S&T) Cluster, an initiative spearheaded by the Office of Principal Scientific Advisor (PSA) to the Government of India. Launched in 2017 by the Government of Telangana, RICH acts as a facilitator and aims to foster greater collaboration between various entities in the research and innovation space. RICH has initiated multidisciplinary projects in the areas of agriculture, nutrition, health, and waste management. These projects leverage the local expertise and strengths of Telangana, and facilitate ease of access to funding from the relevant central ministries.

About Biocon Foundation

Biocon Foundation, the Corporate Social Responsibility arm of Biocon, Biocon Biologics and Syngene International, is working to empower marginalized communities, since 2005. Biocon Foundation partners with the society to promote social and economic inclusion. It has thus made significant investments in enhancing access to quality healthcare, education and civic infrastructure along with environmental sustainability initiatives. These programs create a momentum to elevate the vulnerable and underserved sections of the society. The Foundation has built a strong reputation for the quality of its programs and their impact in addressing social, humanitarian and environmental challenges faced by the communities it serves. The programs have contributed to realizing the vision of empowering and integrating the underprivileged into the social and economic mainstream of India.

 

Cision View original content:https://www.prnewswire.com/in/news-releases/syngene-announces-second-year-of-stem-scholarship-and-mentorship-program-for-women-in-collaboration-with-rich-302176816.html

Comments (0)

Login to join the conversation

Login / Register

No comments yet. Be the first to comment!

More to Read

3iQ and Bhutan's Gelephu Mindfulness City Announce Strategic Partnership to Advance GMC's Digital Asset Ambitions
news
Jul 30, 2026 1 min

3iQ and Bhutan's Gelephu Mindfulness City Announce Strategic Partnership to Advance GMC's Digital Asset Ambitions

3iQ secures a dedicated mandate to manage a portion of Gelephu Mindfulness City s (GMC) Bitcoin reserves. 3iQ and GMC will collaborate closely to support the vision of building a next-generation institutional-grade digital asset management ecosystem focused on innovation and sustainability. TORONTO and GELEPHU, Bhutan , July 30, 2026 -- 3iQ Corp. ( 3iQ ), a global pioneer in digital asset investment solutions, and Gelephu Mindfulness City, a Special Administrative Region in southern Bhutan, today announced a strategic partnership to advance GMC s building of a leading digital asset fund ecosystem. As part of the partnership, 3iQ will manage a dedicated mandate backed by a portion of GMC s bitcoin treasury, while also investing in local talent and knowledge transfer, and establishing a long-term presence in the city to help build GMC into Bhutan s new digital offshore financial hub .

Milken Institute Unveils Details for 2026 Asia Summit, Calls for Smart Leadership in an AI-Driven World
news
Jul 30, 2026 1 min

Milken Institute Unveils Details for 2026 Asia Summit, Calls for Smart Leadership in an AI-Driven World

Returning for its 13th edition, this year s Asia Summit puts the spotlight on artificial intelligence with public sessions and private roundtables tailored to the topic SINGAPORE , July 30, 2026 -- Amid escalating global geopolitical tensions and the rapid advancement of technology, the Milken Institute announces the return of its Milken Institute Asia Summit . The Milken Institute Asia Summit is an annual convening that gathers over 1,500 C-suite executives, business leaders, global investors, policymakers, philanthropists, and innovators to address critical issues affecting the Asia-Pacific region. The 2026 Asia Summit will take place October 7 9 at the Four Seasons Hotel Singapore.

Milliken Begins Commercial Production of Millad ClearX™ 9000 to Support Growing Demand for Advanced Polypropylene Solutions
news
Jul 30, 2026 1 min

Milliken Begins Commercial Production of Millad ClearX™ 9000 to Support Growing Demand for Advanced Polypropylene Solutions

MUMBAI, India , July 30, 2026 -- Milliken & Company today announced the successful startup of dedicated production capacity for Millad ClearX 9000, the company s fifth-generation clarifier technology designed to deliver exceptional clarity, performance, and processing efficiency in polypropylene applications. The new manufacturing capability strengthens Milliken s ability to support customers with reliable supply, consistent quality, and continued innovation as demand for advanced polypropylene solutions grows wordwide.

BluPine Energy Strengthens Rajasthan C&I Portfolio with Multiple Renewable Power Agreements; Targets 150MW Commercial & Industrial Capacity
news
Jul 30, 2026 1 min

BluPine Energy Strengthens Rajasthan C&I Portfolio with Multiple Renewable Power Agreements; Targets 150MW Commercial & Industrial Capacity

GURUGRAM, India , July 30, 2026 -- BluPine Energy, one of India s leading renewable energy platforms established by Actis, has strengthened its Commercial & Industrial (C&I) presence in Rajasthan with the execution of long-term Power Purchase Agreements (PPAs) with KEI Industries Limited , Craftsman Automation Limited , and Sunbeam Lightweighting Solutions Private Limited . Together, these projects represent another milestone in BluPine Energy s strategy to provide reliable, cost-effective renewable energy solutions to India s industrial sector while expanding its C&I footprint across key manufacturing hubs. Construction activities for all three projects have commenced, with commissioning planned in line with project timelines.

Esentia Announces Confidential Submission of Draft Registration Statement to SEC for Proposed Initial Public Offering in the U.S.
news
Jul 30, 2026 1 min

Esentia Announces Confidential Submission of Draft Registration Statement to SEC for Proposed Initial Public Offering in the U.S.

NEW YORK , July 30, 2026 -- Esentia Energy Development, S.A.B. de C.V. ( Esentia ) today announced that it has confidentially submitted a draft Registration Statement on Form F-1 to the U.S. Securities and Exchange Commission (the SEC ) relating to a proposed initial public offering of American depositary shares representing its shares of common stock ( ADSs ) on a U.S. stock exchange. The timing and number of ADSs to be offered have not yet been determined. The proposed initial public offering is expected to take place after the SEC completes its review process, subject to market and other conditions.

TripGain Releases 'State of Business Travel in India 2026' Report, Revealing Persistent Gaps Between Digital Adoption and Operational Reality
news
Jul 30, 2026 1 min

TripGain Releases 'State of Business Travel in India 2026' Report, Revealing Persistent Gaps Between Digital Adoption and Operational Reality

Industry study of 200+ HR, Finance, IT, leadership, and business travel professionals uncover surprising disconnects between finance priorities, traveler expectations, and technology adoption. BANGALORE, India , July 30, 2026 -- Conventional wisdom suggests corporate travel technology is primarily about reducing costs and automating bookings. However, a new industry study from TripGain suggests something far more significant is happening.

XCMG's First Overseas New Energy Factory Commences Production in Indonesia
news
Jul 30, 2026 1 min

XCMG's First Overseas New Energy Factory Commences Production in Indonesia

WEDA, Indonesia , July 30, 2026 -- XCMG (SHE: 000425) held an inauguration ceremony for its Indonesia New Energy Manufacturing Base (the Base ) on July 27 at Indonesia Weda Bay Industrial Park (IWIP) in North Maluku Province. With the first batch of new energy equipment rolling off the production line and being delivered to strategic partner Tsingshan Holding Group s IWIP, XCMG s first overseas new energy factory commenced production. XCMG is accelerating its five-pronged transformation toward high-end, intelligent, green, global and service-oriented development, with global operations and green industrial development as two core strategic priorities. The launch of XCMG s first overseas new energy factory represents a strategic move integrating these priorities.

Medidata Launches Medidata Plus, an AI-Native Foundation Built to Scale Clinical Portfolios
news
Jul 30, 2026 1 min

Medidata Launches Medidata Plus, an AI-Native Foundation Built to Scale Clinical Portfolios

Built on an award-winning AI foundation, Medidata Plus removes traditional barriers, empowering sponsors and CROs to scale intelligence across entire portfolios SINGAPORE , July 30, 2026 -- Medidata , a Dassault Syst mes brand and leading provider of clinical trial solutions, today announced the launch of Medidata Plus . This clinical artificial intelligence layer unlocks the full breadth of AI capabilities across the Medidata Platform, giving sponsors access to scalable, outcome-driven AI throughout their global portfolios. Medidata Plus shifts the life sciences industry away from a legacy of disjointed, inefficient point solutions to a unified, end-to-end AI strategy, accelerating the delivery of life-saving therapies to patients.